866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Chemotherapy-Induced Nausea and Vomiting Drugs Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 104 Pages

In this report, the EMEA Chemotherapy-Induced Nausea and Vomiting Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Chemotherapy-Induced Nausea and Vomiting Drugs for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Chemotherapy-Induced Nausea and Vomiting Drugs market competition by top manufacturers/players, with Chemotherapy-Induced Nausea and Vomiting Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Chemotherapy-Induced Nausea and Vomiting Drugs for each application, including
Serotonin Receptor Antagonists
NK1 Receptor Antagonists

Table of Contents

EMEA (Europe, Middle East and Africa) Chemotherapy-Induced Nausea and Vomiting Drugs Market Report 2017
1 Chemotherapy-Induced Nausea and Vomiting Drugs Overview
1.1 Product Overview and Scope of Chemotherapy-Induced Nausea and Vomiting Drugs
1.2 Classification of Chemotherapy-Induced Nausea and Vomiting Drugs
1.2.1 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Existing Drugs
1.2.4 Akynzeo (Netupitant-Palonosetron FDC)
1.2.5 Aloxi (Palonosetron)
1.2.6 Emend (Aprepitant)
1.2.7 Kytril Generic (Granisetron)
1.2.8 Zofran Generic (Ondansetron)
1.2.9 Pipeline Drugs
1.2.10 SUSTOL (Granisetron Injection extended release)
1.2.11 Rolapitant
1.3 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Market by Application/End Users
1.3.1 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Serotonin Receptor Antagonists
1.3.3 NK1 Receptor Antagonists
1.4 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Market by Region
1.4.1 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Chemotherapy-Induced Nausea and Vomiting Drugs (2012-2022)
1.5.1 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2022)
1.5.2 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Market Competition by Players/Manufacturers
2.1.1 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Share by Players (2012-2017)
2.1.3 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sale Price by Players (2012-2017)
2.2 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs (Volume and Value) by Type/Product Category
2.2.1 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sale Price by Type (2012-2017)
2.3 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs (Volume) by Application
2.4 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs (Volume and Value) by Region
2.4.1 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price by Region (2012-2017)

3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Value (2012-2017)
3.1.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share by Type
3.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share by Application
3.4 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by Countries (2012-2017)
3.4.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Countries (2012-2017)
3.4.3 Germany Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
3.4.4 France Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
3.4.5 UK Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
3.4.6 Russia Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
3.4.7 Italy Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
3.4.8 Benelux Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)

4 Middle East Chemotherapy-Induced Nausea and Vomiting Drugs (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Value (2012-2017)
4.1.1 Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share by Type
4.3 Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share by Application
4.4 Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by Countries (2012-2017)
4.4.2 Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
4.4.4 Israel Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
4.4.5 UAE Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
4.4.6 Iran Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)

5 Africa Chemotherapy-Induced Nausea and Vomiting Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Value (2012-2017)
5.1.1 Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share by Type
5.3 Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share by Application
5.4 Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by Countries (2012-2017)
5.4.2 Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Countries (2012-2017)
5.4.3 South Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
5.4.5 Egypt Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
5.4.6 Algeria Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)

6 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturers/Players Profiles and Sales Data
6.1 Merck & Co., Inc.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline plc
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Tesaro, Inc.
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Helsinn Group
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 F. Hoffmann-La Roche Ltd.
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Heron Therapeutics, Inc.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Dr. Reddy's Laboratories Ltd.
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Acacia Pharma
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sun Pharmaceutical Industry Ltd.
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Otsuka Holdings Co., Ltd.
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Cost Analysis
7.1 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Chemotherapy-Induced Nausea and Vomiting Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast (2017-2022)
11.1 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Existing Drugs Product Picture
Figure Akynzeo (Netupitant-Palonosetron FDC) Product Picture
Figure Aloxi (Palonosetron) Product Picture
Figure Emend (Aprepitant) Product Picture
Figure Kytril Generic (Granisetron) Product Picture
Figure Zofran Generic (Ondansetron) Product Picture
Figure Pipeline Drugs Product Picture
Figure SUSTOL (Granisetron Injection extended release) Product Picture
Figure Rolapitant Product Picture
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Application in 2016
Figure Serotonin Receptor Antagonists Examples
Figure NK1 Receptor Antagonists Examples
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Players (2012-2017)
Figure 2016 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Players
Figure 2017 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Players
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Players
Table 2017 EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Players
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2012-2017)
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2012-2017)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type in 2016
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Application (2012-2017)
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2016
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Region (2012-2017)
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in 2016
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Region (2012-2017)
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Regions in 2016
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2012-2017)
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Type (2012-2017)
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Type (2012-2017)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Type in 2016
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Application (2012-2017)
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Application (2012-2017)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Application in 2016
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Countries (2012-2017)
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Countries in 2016
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Countries in 2016
Figure Germany Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure France Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UK Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Type (2012-2017)
Table Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Type (2012-2017)
Figure Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Type (2012-2017)
Table Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Applications (2012-2017)
Table Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Applications (2012-2017)
Figure Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2016
Table Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Type (2012-2017)
Table Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2012-2017)
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2012-2017)
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2016
Table Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Application (2012-2017)
Table Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2012-2017)
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2012-2017)
Table Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Countries in 2016
Table Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Countries in 2016
Figure South Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in EMEA (2012-2017)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in EMEA (2012-2017)
Table Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in EMEA (2012-2017)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in EMEA (2012-2017)
Table Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in EMEA (2012-2017)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in EMEA (2012-2017)
Table Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in EMEA (2012-2017)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in EMEA (2012-2017)
Table Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in EMEA (2012-2017)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in EMEA (2012-2017)
Table Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in EMEA (2012-2017)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in EMEA (2012-2017)
Table Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in EMEA (2012-2017)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in EMEA (2012-2017)
Table Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in EMEA (2012-2017)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
Table Raw Materials Sources of Chemotherapy-Induced Nausea and Vomiting Drugs Major Manufacturers in 2016
Table Major Buyers of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Distributors/Traders List
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *